As a member of the family of receptor tyrosine kinases (RTK), EphA2 plays a critical role in embryonic patterning, neuronal targeting, vascular development, and tumor progression, especially in EMT, which it is an attractive target for cancer therapy [24–26]. This evidence concerns the gene EPHA2 and neoplasm.